Novel endoluminal parameters to predict primary loss of response in patients with Crohn's disease: a national survey and multi-centre study

被引：0
|
作者：
Shen, J. [1 ]
Feng, Q. [2 ]
Yao, R. [1 ]
Cai, C. [1 ]
Liang, J. [3 ]
Tian, F. [4 ]
Cao, X. [5 ]
Li, Y. [6 ]
Gu, Y. [7 ]
机构：
[1] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Div Gastroenterol & Hepatol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China
[3] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Peoples R China
[4] China Med Univ, Shengjing Hosp, Dept Gastroenterol, Shenyang, Peoples R China
[5] Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China
[7] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gastroenterol, Shanghai, Peoples R China
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0542
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0368
引用
收藏
页码：i845 / i847
页数：3
相关论文
共 50 条
  • [1] Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study
    Shitrit, A. Bar-Gil
    Siterman, M.
    Waterman, M.
    Hirsh, A.
    Khoury, T.
    Schwartz, D.
    Zittan, E.
    Adler, J.
    Koslowsky, B.
    Avni-Biron, I.
    Chowers, Y.
    Ron, Y.
    Israeli, E.
    Ungar, B.
    Yanai, H.
    Maharshak, N.
    Ben-Horin, S.
    Ben-Ya'acov, A.
    Eliakim, R.
    Dotan, I.
    Goldin, E.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S399 - S400
  • [2] DISCONTINUATION OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: MULTI-CENTRE REAL WORLD DATA
    Fenech, Valerie Anne
    Kamperidis, Nikolaos
    Hart, Ailsa
    Thoua, Nora
    Cole, Alexander
    Segal, Jonathan
    Peake, Simon
    Arebi, Naila
    GUT, 2021, 70 : A93 - A94
  • [3] Novel electrocardiographic parameters for the detection of Fabry Disease - A comparative multi-centre study
    Namdar, M.
    Richardot, P. H.
    Olivotto, I.
    Nordbeck, P.
    MacFarlane, P.
    EUROPEAN HEART JOURNAL, 2018, 39 : 460 - 461
  • [4] Adalimumab drug levels at secondary loss of response in Crohn's disease; are we aiming high enough? A retrospective, international multi-centre study
    Swaine, A.
    Reynolds, R.
    Roblin, X.
    Gibson, D.
    Martin, C.
    Irving, P.
    Sparrow, M.
    Ward, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S571 - S572
  • [5] Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study
    Biron, C.
    Seksik, P.
    Nachury, M.
    Nancey, S.
    Bouhnik, Y.
    Serrero, M.
    Armengol-Debeir, L.
    Buisson, A.
    Minh, M. -L. Tran
    Zallot, C.
    Fumery, M.
    Bouguen, G.
    Abitbol, V.
    Viennot, S.
    Chanteloup, E.
    Rajca, S.
    Dib, N.
    Peyrin-Biroulet, L.
    Vuitton, L.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S77 - S77
  • [6] Efficacy of ustekinumab in perianal Crohn's disease: the BioLAP multi-centre observational study
    Biron, C.
    Seksik, P.
    Nachury, M.
    Bouhnik, Y.
    Amiot, A.
    Viennot, S.
    Serrero, M.
    Fumery, M.
    Allez, M.
    Siproudhis, L.
    Buisson, A.
    de Chambrun, G. Pineton
    Abitbol, V.
    Nancey, S.
    Caillo, L.
    Plastaras, L.
    Armengol-Debeir, L.
    Chanteloup, E.
    Simon, M.
    Dib, N.
    Rajca, S.
    Amil, M.
    Peyrin-Biroulet, L.
    Vuitton, L.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S74 - S75
  • [7] ADALIMUMAB DRUG LEVELS AT SECONDARY LOSS OF RESPONSE IN CROHN'S DISEASE; ARE WE AIMING HIGH ENOUGH? A RETROSPECTIVE, INTERNATIONAL MULTI-CENTRE STUDY.
    Swaine, Adrian
    Reynolds, Rebecca
    Roblin, Xavier
    Gibson, David J.
    Martin, Catherine A.
    Irving, Peter M.
    Sparrow, Miles
    Ward, Mark G.
    GASTROENTEROLOGY, 2020, 158 (06) : S464 - S464
  • [8] CT-based body composition parameters predict the loss of response to infliximab in patients with Crohn's disease
    Li, Shaotang
    Wu, Hao
    Miao, Shouliang
    Huang, Chen
    Zhang, Yini
    Shao, Xinyi
    Chen, Chao
    Wu, Xiaoli
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369 (02): : 189 - 196
  • [9] CLINICAL, BIOMARKER AND ENDOSCOPIC OUTCOMES IN PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB: MULTI-CENTRE REAL WORLD STUDY
    Kamperidis, Nikolaos
    Fenech, Valerie
    Thoua, Nora
    Cole, Alexander
    Segal, Jonathan
    Peake, Simon
    Arebi, Naila
    GASTROENTEROLOGY, 2021, 160 (06) : S705 - S706
  • [10] Nomogram to predict primary non-response to infliximab in patients with Crohn's disease: a multicenter study
    Ye, Xiao-Qi
    Cai, Jing
    Yu, Qiao
    Cao, Xiao-Cang
    Chen, Yan
    Rao, Mei-Xin
    Chen, Bai-Li
    He, Yao
    Zeng, Zhi-Rong
    Chen, Hao
    Lin, Yi-Mou
    Cao, Qian
    Chen, Min-Hu
    Zhang, Sheng-Hong
    GASTROENTEROLOGY REPORT, 2021, 9 (04): : 329 - 338
12345